FDA approves new MPN drug that Mays Cancer Center director helped develop
September 9, 2019
SAN ANTONIO (Sept. 9, 2019) ̶ September is Blood Cancer Awareness Month, and this year patients with myelofibrosis, a rare blood cancer, have reason to celebrate. In mid-August, the U.S. Food and Drug Administration approved the first new medication in nearly a decade for patients with myelofibrosis. Ruben Mesa, M.D., FACP, was part of the […]
